Juvéderm Skinvive

Juvéderm Skinvive is a hyaluronic acid injectable by Allergan Aesthetics, created to improve the quality of the skin and to correct superficial skin depressions. Juvéderm Volite is now presented under the name SKINVIVE by JUVÉDERM. Authorised medical practitioners use it to treat fine lines and to improve the hydration and elasticity of the skin. Its formula holds cross-linked hyaluronic acid at 12 mg/mL and 3 mg/mL of lidocaine hydrochloride in a phosphate buffer at pH 7.2, for professional use. A box contains two 1 mL pre-filled syringes, four single-use 32G 1/2" needles and traceability labels.

• Injectable implant for superficial cutaneous depressions such as fine lines, and for improvement of skin quality attributes including hydration and elasticity
• Hyaluronic acid gel 12.0 mg with lidocaine hydrochloride 3.0 mg per mL, in phosphate buffer at pH 7.2
• Cross-linked hyaluronic acid of non-animal origin, sterile and pyrogen-free
• A skin quality treatment rather than a volumising filler, so it addresses hydration and surface texture instead of contour
• Supplied with 32G 1/2 inch needles, consistent with intra-dermal placement
• Contains lidocaine, so no separate anaesthetic is needed at the injection site
• Each box holds two 1 mL syringes with four single-use needles and traceability labels
• CE marked, for professional use only
• Manufactured by Allergan in Annecy, France

適応と専門的な使用

主な適応

• Superficial cutaneous depressions such as fine lines, by intra-dermal injection
• Improvement of skin quality attributes such as hydration
• Improvement of skin quality attributes such as elasticity

専門的な使用

SKINVIVE by Juvéderm is an injectable medical device intended for intra-dermal injection by an authorised medical practitioner in accordance with local applicable regulation. It is for professional use only, is not for retail sale to consumers and never for self-administration. The technique and volume per site are selected by the treating practitioner. It must not be injected in the eyelids. It must not be injected into blood vessels, since intravascular injection may lead to embolisation, occlusion of the vessels, ischaemia or infarction, and it must not be overcorrected. It must not be used simultaneously with laser treatment, deep chemical peels or dermabrasion; for surface peels, injection is not recommended where the inflammatory reaction is significant. SKINVIVE is a skin quality treatment and is not interchangeable with the deeper-placed volumising references in the range.

施術部位

• Superficial cutaneous depressions such as fine lines, by intra-dermal injection

対象となる患者

For adult patients assessed as suitable by the treating practitioner. Selection, injected volume, plane and technique follow clinical assessment by the practitioner. The product must not be used in patients suffering from untreated epilepsy, patients who tend to develop hypertrophic scarring, patients with known hypersensitivity to hyaluronic acid or to gram-positive bacterial proteins, patients with known hypersensitivity to lidocaine or to amide-type local anaesthetics, patients suffering from porphyria, women who are pregnant or breastfeeding, or children. It must not be used in areas presenting cutaneous inflammatory or infectious processes such as acne or herpes.

作用の仕組み： Juvéderm Skinvive ​

Allparaで注文する理由

Allparaは、正規品で検証済みの JUVÉDERM 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問